Cost‐effectiveness of prophylactic emicizumab versus prophylactic recombinant factor VIII in patients with moderate or mild hemophilia A without inhibitors in the United States
| Publication | Article in American Journal of Hematology, published July 2023 |
|---|---|
| Authors | Kunal C. Potnis, Giri Viswanathan, Robert D. Bona, Satoko Ito, Christine L. Kempton, Ankur Pandya...[ show more ] |
This is the public page for a publication record in Dimensions, a free research insights platform that brings together information about funding, scholarly outputs, policy, patents and grants.
Loading metrics…